Collegium Pharmaceutical (COLL) Tax Provisions (2020 - 2026)

Collegium Pharmaceutical's Tax Provisions history runs 7 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• In Q1 2026, Tax Provisions rose 501.99% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $33.3 million (up 57.21% YoY), while the FY2025 annual figure was $29.7 million, up 1.26% from the prior year.
• Tax Provisions was $4.2 million for Q1 2026 at Collegium Pharmaceutical, down from $12.1 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $14.8 million in Q4 2023 to a low of -$2.8 million in Q1 2022.
• Historically, Tax Provisions has averaged $5.1 million across 5 years, with a median of $4.8 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions slumped 1375.0% in 2022, then soared 6900.76% in 2024.
• A 5-year view of Tax Provisions shows it stood at -$592000.0 in 2022, then surged by 2594.93% to $14.8 million in 2023, then tumbled by 67.96% to $4.7 million in 2024, then soared by 155.08% to $12.1 million in 2025, then tumbled by 64.85% to $4.2 million in 2026.
• The last three Tax Provisions figures came in at $4.2 million (Q1 2026), $12.1 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.